Cefazolin PK Study 3g vs 2g
Clinical trial NCT05309304 · COMPLETED
Trial details
- NCT number
- NCT05309304
- Sponsor
- Baxter Healthcare Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2022-08-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.